CANDEL THERAPEUTICS, INC. (CADL)
Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Asana to Announce First Quarter Fiscal Year 2027 Financial Results on Thursday, May 28, 2026
Extreme Networks Announces Investor Conferences for May and June 2026
Reinsurance Group of America Announces Redemption of All of Its Outstanding 5.75% Fixed-to-Floating Rate Subordinated Debentures Due 2056